Therigy Debuts RSV Solution for TherigySTM

Maitland, FL (November 10, 2014) — Therigy today announced the release of a new module, Respiratory Syncytial Virus (RSV), within its specialty therapy management application TherigySTM. Currently,...

  Partner with Therigy to conduct outcomes studies based on real-world evidence across 20+ specialty disease states and 400+ specialty medications.
Learn More